The latest announcement is out from GeneTether Therapeutics, Inc. ( ($TSE:GTTX) ). Rize Oncology, formerly GeneTether Therapeutics, has announced ...

Patients of European ancestry are more likely to find a match to the latest targeted cancer drugs than patients of other ...

Each year, over 1.2 million Americans receive a cancer diagnosis, a journey that can be both overwhelming and daunting.

We recently compiled a list of the 12 Best Penny Stocks to Invest in According to the Media. In this article, we are going to ...

Oral cancer is an increasingly prevalent disease worldwide, with over 300,000 new cases diagnosed each year. Among oral cancers, tongue cancer (TC) is the most common type and often carries a poor ...

In this second half of our interview with Vanderbilt University Medical Center’s Travis Osterman, DO, MS, FAMIA, FASCO, he discusses opportunities for advancing the smart use of artificial ...

TD Cowen analyst Tyler Van Buren initiated coverage of CG Oncology (CGON) with a Buy rating and no price target The firm says cretostimogene ...

Boehringer Ingelheim and Synaffix B.V. ("Synaffix"), a Lonza company (SWX:LONN) focused on commercializing its clinical-stage platform technology for the development of best-in-class antibody-drug ...

Mural nominated two new development candidates, MURA-8518 a novel binding protein-resistant IL-18 with half-life extension, ...

Taiho Oncology, Inc. announced today presentations at the 2025 ASCO Gastrointestinal Cancers Symposium (ASCO GI), to be held ...

Combination creates immediate scientific synergies by harnessing complementary AI / ML platforms to improve patient outcomes across multiple ...